Related Experiment Videos
Cyclic AMP opposes IP3-induced calcium release from permeabilized human platelets.
1Department of Biochemistry, Medical School, University of Minnesota, Minneapolis 55455.
Second Messengers and Phosphoproteins
|January 1, 1988
Summary
Platelets take up calcium after electrical stimulation. Cyclic AMP (cAMP) inhibits calcium release triggered by inositol trisphosphate (IP3), suggesting a role in preventing blood clots.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Platelets play a crucial role in hemostasis and thrombosis.
- Calcium ions (Ca++) are critical regulators of platelet activation and function.
- Inositol-1,4,5-trisphosphate (IP3) is a key signaling molecule involved in intracellular calcium release.
Purpose of the Study:
- To investigate the effect of electrical permeabilization on platelet calcium uptake.
- To examine the influence of inositol-1,4,5-trisphosphate (IP3) and adenosine 3':5'-cyclic monophosphate (cAMP) on platelet calcium dynamics.
- To explore the potential role of cAMP in modulating IP3-mediated calcium release in platelets.
Main Methods:
- Platelet permeabilization using high voltage electric fields.
- Measurement of 45Ca++ uptake and release in response to IP3 and cAMP.
- Concentration-dependent analysis of cAMP's effect on IP3-mediated calcium release.
Main Results:
- Permeabilized platelets exhibited time- and ATP-dependent 45Ca++ uptake.
- Submicromolar IP3 induced rapid 45Ca++ release followed by slower reuptake.
- cAMP inhibited IP3-mediated calcium release in a concentration-dependent manner (1-100 microM) without affecting basal uptake.
Conclusions:
- cAMP modulates platelet calcium signaling by inhibiting IP3-induced calcium release.
- This cAMP-mediated inhibition may contribute to the antithrombotic effects of agents that increase cAMP levels.
- Understanding these mechanisms is vital for developing novel antithrombotic therapies.